Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DG5: Oral Hypoglycemic Agents vs Insulin in Gestational Diabetes
NCT01215331Phase 3Completed
- Sponsor
- Université de Sherbrooke
- Start
- Aug 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs), glibenclamide in gestational diabetes mellitus (GDM), sponsored by Université de Sherbrooke. Started Aug 2010; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT01215331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215331.